Dr. Gohar’s group has a particular interest in identifying the role of renal estrogen signaling in the regulation of blood pressure and renal sodium handling.
The current goal of the Gohar Lab research program is to define the molecular mechanisms underlying sex-differences in hypertension and associated cardiovascular and renal disease.
Dr. Eman Gohar’s research program, which spans endocrinology, cardiovascular and renal physiology, has already made significant progress in addressing crucial gaps in our understanding of the female kidney.
The long-term goal of Dr. Gohar’s group is to successfully use a systems biology approach, from a single cell to the whole body, to deepen our understanding of estrogenic signaling in cardiovascular and renal physiology and pathophysiology.
Provide excellence in patient care, train physicians and researchers, lead in scientific research and discoveries in understanding and treating acute and chronic renal disease, and promote collaborations within the scientific domain.
Through the exceptional capabilities and caring spirit of its people, Vanderbilt will lead in improving the healthcare of individuals and communities regionally, nationally and internationally. We will combine our transformative learning programs and compelling discoveries to provide distinctive personalized care.